Health screening decisions
Private health screening:benefits, harms and informed choice.
Screening can identify risk before symptoms appear, but it can also create false alarms, false reassurance and overdiagnosis. The value of a screening test depends on the condition, your risk and the follow-up pathway.
Screening can help, but it can also cause harm.
Screening is testing people who do not have symptoms to find those who may have a higher chance of a condition. A screening test is not a diagnosis. A positive result may lead to more tests, while a negative result cannot guarantee that disease is absent now or in the future. [1]
The UK National Screening Committee only recommends population screening when the evidence shows that the whole pathway, from the first test through diagnosis and treatment, is expected to do more good than harm. [2]
A test only becomes useful screening when the evidence, follow-up pathway and treatment all work together.
Earlier identification may help when an effective treatment or prevention step improves outcomes.
False alarms, false reassurance, overdiagnosis and follow-up procedures can create physical, emotional and financial burden.
Screening is not the right label for investigating symptoms.
UK NSC guidance is explicit that screening is for apparently healthy people. If you already have symptoms, the question is diagnostic assessment rather than screening. [3]
That difference matters because the choice of tests, urgency and interpretation may be completely different. A screening package should not be used to reassure someone whose symptoms need proper medical assessment.
Examples include unexplained bleeding, persistent bowel change, a new breast lump, major unexplained weight loss or other symptoms that may need a symptom-led clinical pathway.
What are false positives and false negatives?
| Result problem | What it means | Why it matters |
|---|---|---|
| False positive | The screening result suggests a higher chance of disease, but follow-up shows the condition is not present. | It can cause anxiety and lead to more tests or procedures that carry their own risks. |
| False negative | The result is reassuring even though the condition is present or develops soon afterwards. | It can create false reassurance and delay assessment if later symptoms are ignored. |
| Uncertain result | The finding is not clearly normal or abnormal. | It may lead to repeat tests, imaging, specialist review or a period of uncertainty. |
UK NSC guidance notes that no screening test is perfect and that both false-positive and false-negative results can cause harm. [1]
What does overdiagnosis mean?
Overdiagnosis means finding a condition that is real but would never have caused symptoms or harmed the person during their lifetime. Once found, it may still lead to more tests or treatment.
This is different from a false positive. In overdiagnosis, the abnormality is genuinely present. The harm comes from identifying a condition that would not have benefited the person to find.
UK screening policy therefore considers the whole balance of benefits and harms, including overdiagnosis, overtreatment and complications from follow-up. [2]
Earlier is not always better.
Early detection is useful when finding the condition earlier improves an outcome that matters. A test should not be judged only by how much disease it can find.
Does private screening offer more than NHS screening?
Private providers may offer tests that are not part of NHS population screening. That does not automatically make the private test better or more thorough.
NHS screening programmes are selected through a national evidence process and include quality assurance, defined eligibility and a follow-up pathway. Some commercial tests are not recommended by the UK NSC because it is unclear that the benefits outweigh the harms. [4]
A private assessment can still be useful when it is personalised to a person's age, family history, existing conditions and risk. The key is to ask why each test is being offered and what would happen after an abnormal result.
How should you decide whether a screening test is worth having?
- What condition is the test looking for?
- Am I in a group for whom screening has evidence of benefit?
- How accurate is the test in people like me?
- What are the false-positive and false-negative risks?
- Could the test find a condition that would never cause harm?
- What diagnostic test follows an abnormal result?
- Is there an effective treatment or prevention step if the condition is confirmed?
- Who owns follow-up and what might it cost?
These questions are close to the principles the UK NSC uses when assessing screening programmes. They also help when you are considering optional private screening. [3]
Age and risk can change the balance.
A screening test that has little value in a low-risk population can be useful in a selected higher-risk group. That is why programmes often use age, sex, genetics or another risk factor to define who should be offered screening.
Prostate screening is a current example. In 2026 the UK NSC recommended a targeted PSA-based programme for a specific group of men with a pathogenic BRCA2 variant and relevant family history, while continuing to recommend against population-wide prostate screening. [5]
This illustrates why screening advice changes with evidence and risk. A broad “cancer blood panel for everyone” is not the same as evidence-based targeted screening.
What should happen before private screening?
A clinician should understand your symptoms, family history, previous screening, medicines and known conditions before recommending tests. If you already have symptoms, screening may not be the right pathway.
You should know what the test is for, its limitations, the follow-up pathway and the cost of any additional assessment. Screening should be a personal informed choice, not something presented as risk-free reassurance. [6]
The related private-health-screening service page is still being prepared on this staging site, so this article does not make promises about a fixed screening panel.
Use a screening decision checklist before you pay
Ask what condition the test is trying to find and whether you have symptoms. Screening is for people without symptoms; symptoms may need a different diagnostic route.
Ask how often the test gives a false alarm, what happens after a positive result and whether follow-up may involve more scans, tests or procedures. Also ask what a negative result can and cannot rule out.
Ask whether the test is recommended for people of your age, sex and risk. A useful screening programme has a defined group because the balance of benefit and harm changes with baseline risk.
Finally, ask what happens if you do nothing now. Some tests are useful only at a certain age or interval. More screening is not always safer, and a test should not create a false sense that all disease has been excluded.
Screening and diagnosis are different jobs
Screening looks for risk or early disease in people who do not have symptoms. Diagnosis starts from a symptom, sign or other concern. The same test can have a different meaning in those two settings.
If you have a new symptom, say so before booking a screening package. A symptom may need a direct medical assessment rather than a broad check designed for people who feel well.
What patients say about the consultation experience.
Patient reviews can help you understand how a consultation feels. They do not prove that a diagnosis will be found or that a treatment will work.
Individual reviews reflect personal experiences and do not predict diagnosis, treatment response or outcome.
“patient, understanding and kind”
Google reviewer
“warm and compassionate bedside manner”
Google reviewer
“takes incredible care to get to know her patients”
Google reviewer
Common questions
Can private health screening find disease earlier?
Sometimes, but earlier detection is only helpful when the test works well in the relevant population and earlier treatment improves outcomes. Screening can also cause false positives, false reassurance and overdiagnosis. The value depends on the condition, the test, your risk and the follow-up pathway. [2]
What is a false positive screening result?
A false positive means the screening test suggests a higher chance of a condition but follow-up testing shows it is not present. False positives can cause anxiety and lead to further tests or procedures. They are one reason screening programmes have to balance potential benefits and harms. [1]
What is overdiagnosis?
Overdiagnosis means finding a real condition that would never have caused symptoms or harm during the person's lifetime. It can lead to treatment that the person would never otherwise have needed. It is different from a false positive because the abnormality is genuinely present.
Is private screening better than NHS screening?
Not automatically. NHS screening programmes are selected using national evidence and quality-assurance criteria. Private screening may offer additional tests, but more tests can also create more uncertain findings or false alarms. Ask what evidence supports each test and what follow-up is available. [4]
Should I have screening if I already have symptoms?
Symptoms usually need diagnostic assessment rather than screening. UK NSC guidance says screening is for people who do not have symptoms. Tell the clinician about symptoms before choosing a screening test so the correct diagnostic or referral pathway can be considered. [3]
How do I decide whether a screening test is worth paying for?
Ask what condition it looks for, whether evidence supports screening someone with your risk profile, the chance of false or unclear results, what follows an abnormal result, whether effective treatment exists and the full cost of follow-up. Screening should be an informed choice, not a promise of reassurance.
Medical sources and further reading
- UK NSC: The pros and cons of screening. Explains false positives, false negatives and the need to balance benefits and harms.
- UK NSC: Criteria for a population screening programme. Includes the need for screening benefits to outweigh overdiagnosis, overtreatment, false positives and false reassurance.
- GOV.UK: NHS and commercial health screening tests. Explains that screening is for people without symptoms and describes benefits, limitations and commercial-screening considerations.
- NHS: NHS screening. Explains NHS screening programmes and notes that some private tests are not recommended by the UK NSC.
- UK NSC: Prostate cancer screening recommendation. Records the 2026 targeted recommendation and continued position against population-wide prostate screening.
- UK NSC: Informed choice. Explains balanced information and personal informed choice in screening.
Good screening does more good than harm.
Ask what the test is for, what can go wrong, and what happens after the result before you decide.